Private Equity and the ENT Practice: What Physicians Should Know

For many ENT practices, a PE partnership can create meaningful opportunities: access to growth capital, operational support, and liquidity for physician owners. PE partnerships also allow practices to offload some of the management and administrative responsibilities associated with running their practices. At the same time, these transactions introduce significant financial, legal, and governance considerations that physicians should carefully evaluate before moving forward. Further, practitioners should understand the short-term benefits and long-term outlooks these deals present to inform their decision making.

For ENT practice leaders considering a potential transaction, understanding the strategic motivations behind PE investment—and the implications for physician practices—is critical.

Why PE Is Interested in Physician Practices

Healthcare represents approximately 22% of the U.S. economy, making it one of the largest and most stable sectors for investment. PE firms are drawn to healthcare because of several structural trends, including an aging population, the rising prevalence of chronic disease, and continued demand for specialty care services. In previous decades, laws and regulations at the state and federal levels have relaxed significantly to allow for more private investment into healthcare entities.

Within physician services, investors often focus on specialties that exhibit several characteristics:

• Fragmented practice landscapes;
• Strong procedural revenue streams;
• Opportunities for ancillary services;
• Potential for operational efficiencies through scale; and
• Geographically controllable markets.

ENT practices often meet many of these criteria. In addition to traditional clinic visits and surgical procedures, many otolaryngology groups generate revenue through ancillary services such as audiology, hearing aid dispensing, allergy testing and immunotherapy, sleep medicine services, and ambulatory surgery center (ASC) participation. For investors, these diversified revenue streams can create opportunities for growth and operational optimization. The more ancillary services and alternative revenue streams that a practice may be able to explore, the more value a centralized PE platform can add.

For a PE investment to make sense for a physician practice group, the investor must see efficiencies or additional revenues that may be captured through a centralized platform that is not currently at full operation within the practice. This makes ENT practices prime candidates, given the wide variety of differing services and coverage offered from practice to practice and the perceived “money left on the table” relating to the costs of administering them on a practice-by-practice basis.

Why ENT Practices Are Exploring PE

Liquidity for practice owners. Many physicians have spent decades building successful practices but have limited opportunities to realize the financial value of those businesses. While salary revenues can be highly competitive, the opportunity for an exit/retirement payment is not ample within the space. A PE transaction can allow physician owners to monetize a portion of the practice’s value while continuing to practice clinically.

In many cases, physicians retain a portion of equity in the platform entity created through the transaction. If the PE sponsor successfully grows the business and sells it in the future, physicians may receive a “second bite at the apple” when the platform is sold again. In other words, most PE deals involve an initial payment for the value of the practice and the potential for a second payment down the line if the business is sold for more money. This makes a PE investment inherently more interesting to physicians looking to receive some sort of consideration for the value of their practice’s growth beyond mere yearly dividends.

Capital to support growth. Many ENT practices are seeking capital to expand services or geographic reach. Common examples include:

• Opening additional clinic locations;
• Expanding ASC ownership or development;
• Scaling audiology and hearing aid programs;
• Investing in allergy services or diagnostics;
• Recruiting additional physicians or subspecialists; and
• Adding additional service lines or research opportunities.

PE investors often provide capital for these initiatives, along with operational infrastructure to support expansion. While the amount of capital is often negotiated slightly up front, the real synergy comes from the parties having a joint interest in growing the value of the practice.

Professionalized management. PE-backed physician platforms frequently develop centralized management organizations to handle administrative functions such as revenue cycle management, human resources, compliance programs, and data analytics. PE platforms may also gain advantages of scale with regard to things like payer contracting and hospital affiliations that can lead to smoother management processes. For some physicians, this shift toward professionalized management allows them to focus more heavily on patient care rather than the operational responsibilities associated with running a practice.

Physician practices also have to be cautious and do their due diligence on any potential PE management, however. The most common reason for a physician investor to regret a PE deal down the line relates to misaligned management styles and objectives. It is crucial that all parties agree on what kind of management is required for the practice to best achieve growth and positive outcomes—before the deal. And it is equally critical for attorneys and advocates to clearly define what control provisions and leverage the parties will keep after closing to ensure there is a shared common focus on management that best serves the providers and the patients.

How PE Values Physician Practices

Most physician practice transactions are priced based on EBITDA (earnings before interest, taxes, depreciation, and amortization) multiplied by a valuation multiple. Most valuations in this space should be handled by valuators with great familiarity with the specific practice of otolaryngology to ensure that industry-specific factors are accounted for. For example, a valuator with no knowledge of the space could ignore an allergy clinic sponsorship that someone in the space would rightly view as incredibly beneficial to the practice.

However, valuation can vary widely depending on several factors, including:

• Size and scale of the practice;
• Growth trajectory;
• Strength of ancillary services;
• Payer mix;
• Geographic market dynamics; and
• Quality of management infrastructure.

In physician services transactions, larger groups that serve as a “platform” practice—the initial acquisition around which additional practices are added—often command higher valuation multiples. Smaller practices acquired later as add-on acquisitions typically trade at lower multiples.

Preparing Your Practice Before Entering the Market

The best thing to do to prepare for a PE sale down the line is to talk to your attorney and your accountant about where the practice stands. A practice with clear and concise governance documents and procedures is much better prepared from a legal standpoint to engage in sale discussions. Similarly, no two corporate structures and compensation arrangements for employees and owners are the same between practices. And this structuring is crucial to evaluate if you want to achieve the highest possible valuation for your practice and to ensure you are taking advantage of any beneficial tax structures in the event of a sale.

Financial preparation. Investors will closely review the financial performance of the practice, including:

• Historical financial statements;
• Revenue by service line;
• Physician compensation models;
• Billing and collections performance; and
• Growth trends.

Many practices engage accounting advisors to conduct a quality-of-earnings analysis before formally launching a sale process. Discussing earnings and projections with a knowledgeable accountant can go a long way toward ensuring you are properly set up for valuation discussions down the line. Getting these records in order is also critical for the forthcoming due diligence required in the acquisition.

Legal and compliance review. Healthcare regulatory compliance is another critical diligence area. Buyers often review issues related to:

• Stark Law compliance;
• Anti-Kickback Statute exposure;
• Fee-splitting arrangements;
• HIPAA compliance; and
• Billing and coding practices.

Addressing potential compliance issues early can prevent delays later in the transaction process. Regulatory issues are the most common reason for a PE deal to fall through once the parties have agreed to terms. Evaluating any risk before the transaction ensures that the parties can clean up the house before inviting a potential PE buyer over for the inspection; it also limits the possibility of unexpected bills relating to a regulatory red flag down the line.

Physician alignment. Perhaps the most important preparation step is ensuring alignment among physician owners regarding long-term strategy. PE partnerships can significantly change governance structures and decision-making authority within a practice. These transactions often involve a changing of the guard in terms of who has decision-making power at a practice-wide level for non-medical decisions. It is crucial to discuss the pros and cons of these changes before going down the path of the deal to avoid unnecessary costs.

The PE Transaction Process

Once a practice begins engaging with potential investors, the transaction process can move quickly. Typical stages include, in the following order:

1. Confidentiality agreements and preliminary discussions;
2. Initial financial review;
3. Letter of intent (LOI);
4. Detailed due diligence by the PE sponsor;
5. Negotiation of transaction documents; and
6. Closing.

The LOI stage is particularly important, as it establishes key economic and structural terms that will guide the remainder of the transaction. It is also worth noting that the due diligence stage can be particularly taxing on practice administrators for practices with poor document retention and management. These deals are often invasive and require a detailed look at the practice; it is always best to get ahead of this if you can.

Governance Changes After a Transaction

While physicians generally retain control over clinical decision making, PE sponsors typically gain authority over many business-related matters, including:

• Strategic expansion decisions;
• Capital expenditures;
• Administrative budgets;
• Operational policies; and
• Growth initiatives.

For physicians accustomed to complete autonomy in practice management, this shift can represent a meaningful cultural adjustment. It is important to discuss what day-to-day operations will look like after closing to ensure everyone is on board.  Common areas of friction for post-transaction challenges include:

• Earnout provisions tied to performance targets;
• Allocation of centralized management costs;
• Differences in growth strategy between physicians and investors;
• Changes in organizational culture as practices scale; and
• Providers wanting more control over the practice after closing than allotted.

Choosing the Right PE Partner

Entering a PE transaction should be viewed as the beginning of a long-term partnership. ENT physicians evaluating potential investors should consider:

• The investor’s experience with ENT practices;
• Operational capabilities in billing, compliance, and payor contracting;
• Track record of successful healthcare investments;
• References from physicians currently partnered with the firm; and
• Alignment of growth strategy and investment timeline.

Final Thoughts

PE investment in otolaryngology is likely to continue growing as healthcare consolidation accelerates. For ENT practices, these partnerships can provide capital for expansion, operational infrastructure, and liquidity for physician owners. At the same time, these transactions represent complex business arrangements that can reshape how a practice operates and change the incentive structures for providers moving forward.

Practices considering this path should take time to understand the legal and financial mechanics of PE transactions, carefully evaluate potential partners, and engage experienced advisors early in the process. Practices should also engage specialists early to discuss the market and what the entire process entails, ensuring people have the full picture before signing on the dotted line.    

Mr. Cilek is a partner in Benesch’s Healthcare Practice Group; he focuses on healthcare law, including regulatory, transactional, and corporate matters.

Mr. Adamson is a managing associate in Benesch’s Healthcare Practice Group, focusing on transactional and regulatory healthcare matters.